Straube Richard

Chairman & CEO

C-suiteM

US·SEC (Form 4)

Soligenix, INC.

0

Total declarations

0

Company

€3,819

▲ Purchases (1 ops.)

—

▼ Sales (0 ops.)

Discover the complete record of transactions filed by Straube Richard, Chairman & CEO. Director active across 1 companies, notably Soligenix, INC.. Cumulatively, 1 reports have been published. Total volume traded: €4k. The latest transaction was disclosed on 18 May 2022 — Acquisition. Regulator: SEC (Form 4). The full history is openly available.

Declarations1 total

Executives▲PurchaseSSoligenix, INC.44SEC

S

Straube RichardSENIOR VICE PRESIDENT AND CMO

€3,8198,000 shares@ €0.47740.072% mcap100.0% of flow

COMMON STOCK

SEC:0001415889-22-005252:0·18 May 2022

Ideal exit: 12 Feb 2023 (T+270)

SEC ↗

1 of 1 declaration

About Straube Richard

Richard Straube is the CEO of SOLIGENIX, INC. As Senior Vice President and CMO, he leads the company's marketing and business development initiatives. His experience in the pharmaceutical sector is a significant asset to SOLIGENIX's growth strategy.